Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
- PMID: 31728650
- DOI: 10.1007/s11912-019-0856-5
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
Abstract
Purpose of review: Management of metastatic head and neck squamous cell cancers (HNSCC) can be challenging. This review gives an insight of current treatment options for patients with synchronous metastatic HNSCC and suggests a therapeutic algorithm.
Recent findings: With the rise of novel therapeutic techniques and medications, many treatment options for both locoregional and distant metastatic disease have become available. The evolving paradigm of metastatic disease now integrates the concept of oligometastatic disease. On top of systemic treatments, patients with low metastatic burden can benefit from curative approaches such as local therapies (surgery, radiotherapy) directed to either primary tumour and distant metastasis. However, data integrating these considerations in the management of metastatic HNSCC is still lacking. Based on this algorithm, we can provide a tailored treatment to each patient with synchronous metastatic HNSCC, according to their age, general condition and metastatic burden.
Keywords: Chemotherapy; Head and neck cancer; Metastases; Radiotherapy; Squamous cell cancer; Treatment algorithm.
Similar articles
-
Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas.Cancer Radiother. 2020 Oct;24(6-7):559-566. doi: 10.1016/j.canrad.2020.05.004. Epub 2020 Aug 1. Cancer Radiother. 2020. PMID: 32753240 Review.
-
Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy.Radiat Oncol. 2025 Mar 6;20(1):31. doi: 10.1186/s13014-025-02610-1. Radiat Oncol. 2025. PMID: 40050916 Free PMC article.
-
De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control "always" matter?Oral Oncol. 2024 May;152:106768. doi: 10.1016/j.oraloncology.2024.106768. Epub 2024 Mar 28. Oral Oncol. 2024. PMID: 38552469 Review.
-
Modern management of distant metastases from head and neck squamous cell carcinoma.Curr Opin Otolaryngol Head Neck Surg. 2025 Apr 1;33(2):115-122. doi: 10.1097/MOO.0000000000001024. Epub 2024 Nov 13. Curr Opin Otolaryngol Head Neck Surg. 2025. PMID: 39560742 Review.
-
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.Oncology. 2020;98(3):179-185. doi: 10.1159/000504651. Epub 2019 Dec 17. Oncology. 2020. PMID: 31846962
Cited by
-
Oligometastatic Head and Neck Cancer: Challenges and Perspectives.Cancers (Basel). 2022 Aug 11;14(16):3894. doi: 10.3390/cancers14163894. Cancers (Basel). 2022. PMID: 36010888 Free PMC article. Review.
-
Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck.Clin Pract. 2025 Jan 17;15(1):21. doi: 10.3390/clinpract15010021. Clin Pract. 2025. PMID: 39851804 Free PMC article.
-
Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8+ T cell antitumor immunity.J Exp Clin Cancer Res. 2024 Sep 30;43(1):270. doi: 10.1186/s13046-024-03191-9. J Exp Clin Cancer Res. 2024. PMID: 39343952 Free PMC article.
-
Vasculogenic mimicry in head and neck tumors: a narrative review.Transl Cancer Res. 2021 Jun;10(6):3044-3052. doi: 10.21037/tcr-21-34. Transl Cancer Res. 2021. PMID: 35116612 Free PMC article. Review.
-
Identifying optimal candidates for primary tumor surgery in patients with metastatic head and neck cancer.Front Surg. 2024 Apr 10;11:1394809. doi: 10.3389/fsurg.2024.1394809. eCollection 2024. Front Surg. 2024. PMID: 38665696 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials